Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.
Mitwasi N, Feldmann A, Arndt C, Koristka S, Berndt N, Jureczek J, Loureiro LR, Bergmann R, Máthé D, Hegedüs N, Kovács T, Zhang C, Oberoi P, Jäger E, Seliger B, Rössig C, Temme A, Eitler J, Tonn T, Schmitz M, Hassel JC, Jäger D, Wels WS, Bachmann M. Mitwasi N, et al. Among authors: berndt n. Sci Rep. 2020 Feb 7;10(1):2141. doi: 10.1038/s41598-020-59082-4. Sci Rep. 2020. PMID: 32034289 Free PMC article.
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.
Aliperta R, Welzel PB, Bergmann R, Freudenberg U, Berndt N, Feldmann A, Arndt C, Koristka S, Stanzione M, Cartellieri M, Ehninger A, Ehninger G, Werner C, Pietzsch J, Steinbach J, Bornhäuser M, Bachmann MP. Aliperta R, et al. Among authors: berndt n. Sci Rep. 2017 Feb 16;7:42855. doi: 10.1038/srep42855. Sci Rep. 2017. PMID: 28205621 Free PMC article.
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Mitwasi N, Feldmann A, Bergmann R, Berndt N, Arndt C, Koristka S, Kegler A, Jureczek J, Hoffmann A, Ehninger A, Cartellieri M, Albert S, Rossig C, Ehninger G, Pietzsch J, Steinbach J, Bachmann M. Mitwasi N, et al. Among authors: berndt n. Oncotarget. 2017 Sep 18;8(65):108584-108603. doi: 10.18632/oncotarget.21017. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312553 Free PMC article.
Theranostic CAR T cell targeting: A brief review.
Arndt C, Bachmann M, Bergmann R, Berndt N, Feldmann A, Koristka S. Arndt C, et al. Among authors: berndt n. J Labelled Comp Radiopharm. 2019 Jun 30;62(8):533-540. doi: 10.1002/jlcr.3727. Epub 2019 Jun 6. J Labelled Comp Radiopharm. 2019. PMID: 30889625 Review.
Conventional CARs versus modular CARs.
Feldmann A, Arndt C, Koristka S, Berndt N, Bergmann R, Bachmann MP. Feldmann A, et al. Among authors: berndt n. Cancer Immunol Immunother. 2019 Oct;68(10):1713-1719. doi: 10.1007/s00262-019-02399-5. Epub 2019 Sep 21. Cancer Immunol Immunother. 2019. PMID: 31542798 Free PMC article. Review.
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells.
Arndt C, Loureiro LR, Feldmann A, Jureczek J, Bergmann R, Máthé D, Hegedüs N, Berndt N, Koristka S, Mitwasi N, Fasslrinner F, Lamprecht C, Kegler A, Hoffmann A, Bartsch T, Köseer AS, Egan G, Schmitz M, Hořejší V, Krause M, Dubrovska A, Bachmann M. Arndt C, et al. Among authors: berndt n. Oncoimmunology. 2020 Apr 5;9(1):1743036. doi: 10.1080/2162402X.2020.1743036. eCollection 2020. Oncoimmunology. 2020. PMID: 32426176 Free PMC article.
167 results